Palmoplantar pustulosis treated with itraconazole: A single, active-arm pilot study: Hottopcs

Dermatologic Therapy

Volumn 22, Issue 1, 2009, Pages 85-89

  V'Lckova Laskoska, M T ^a,b   Caca Biljanovska, N G ^b   Laskoski, D S ^b   Kamberova, S J ^b  

^a University Sts Cyrilus and Methodius ^*  (United States)

^b SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

Itraconazole; Palmoplantar amicrobic pustulosis; Palmoplantar pustular psoriasis; Palmoplantar pustulosis; Pustulosis palmaris et plantaris

Indexed keywords

ITRACONAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG SAFETY; ERYTHEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HISTOLOGY; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAINTENANCE DRUG DOSE; NEURALGIA; PILOT STUDY; PUSTULE; PUSTULOSIS PALMOPLANTARIS; RELAPSE; REMISSION; SIDE EFFECT; SKIN EXFOLIATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 60649117015     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2008.01219.x     Document Type: Article

References (26)

1. Asumalahti K, Veal C, Laitinen T, Suomela S, Allen M, Elomaa O, et al. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum Mol Genet 2002 : 11 (5 589 597.
2. Mossner R, Kingo K, Kleensang A, Krüger U, König IR, Silm H, et al. Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol 2005 : 124 (1 282 284.
3. Edlund E, Johnsson U, Lidgren L, Pettersson H, Sturfelt G, Svensson B, et al. Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis 1988 : 47 (10 809 815.
4. Rosen K, Mobacken H, Nilsson LA. Increased prevalence of antithyroid antibodies and thyroid diseases in pustulosis palmoplantaris. Acta Derm Venereol 1981 : 61 (3 237 240.
5. Rosen K, Lindstedt G, Mobacken H, Nystrom E. Thyroid function in patients with pustulosis palmoplantaris. J Am Acad Dermatol 1988 : 19 (6 1009 1016.
6. Nymann P, Kollerup G, Jemec GBE, Grossmann E. Decreased bone mineral density in patients with pustulosis palmaris et plantaris. Dermatology 1996 : 192 (4 307 311.
7. O'Doherty CJ, MacIntyre C. Palmoplantar pustulosis and smoking. BMJ (Clinical Research Ed) 1985 : 291 (6499 861 864.
8. Saez-Rodriguez M, Noda-Cabrera A, Garcia-Bustinduy M, Gulmera-Martin-Neda F, Dorta-Alom S, Escoda-Garcia M, et al. Palmoplantar pustulosis associated with gastric Helicobacter pylori infection. Clin Exp Dermatol 2002 : 27 (8 720.
9. Hubner AM, Tenbaum SP. Complete remission of palmoplantar psoriasis through Helicobacter pylori eradication: a case report. Clin Exp Dermatol 2008 : 33 (3 339 340.
10. Saez-Rodriguez M, Noda-Cabrera A, Alvarez-Tejera S, Gulmera-Martin-Neda F, Dorta-Alom S, Escoda-Garcia M, et al. The role of psychological factors in palmoplantar pustulosis. J Eur Acad Dermatol Venereol 2002 : 16 (4 325 327.
11. Takematsu H, Isono N, Kato T, Tagami H. Normal human epidermal keratinocyte-derived neutrophil chemotactic factor. Tohoku J Exp Med 1990 : 162 (1 1 13.
12. Takematsu H, Tagami H. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 1993 : 129 (1 74 80.
13. Eriksson MO, Hagforsen E, Lundin IP, Michaelsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol 1998 : 138 (3 390 398.
14. Steinhilber D, Jaschonek K, Knospe J, Morof O, Roth HJ. Effects of novel antifungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathway. Arzneimittelforschung 1990 : 40 (11 1260 1263.
15. Vuddhakul V, Mai GT, McCormack JG, Seow WK, Thong YH. Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole. Int J Immunopharmacol 1990 : 12 (6 639 645.
16. Mihara M, Hagari Y, Morimura T, Nakayama H, Isihara M, Aki T, et al. Itraconazole as a new treatment for pustulosis palmaris et plantaris. Arch Dermatol 1998 : 134 (5 639 640.
17. Kragballe K, Larsen FG. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis. Acta Derm Venereol 1991 : 71 (6 540 542.
18. Layton AM, Sheehan-Dare R, Cunliffe WJ. A double-blind, placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis. Br J Dermatol 1991 : 124 (6 581 584.
19. Lindelof B, Beitner H. The effect of grenz ray therapy on pustulosis palmoplantaris. A double-blind bilateral trial. Acta Derm Venereol 1990 : 70 (6 529 531.
20. Murray D, Corbett MF, Warin AP. A controlled trial of photochemotherapy for persistent palmoplantar pustulosis. Br J Dermatol 1980 : 102 (6 659 663.
21. Rosen K, Mobacken H, Swanbeck G. PUV A, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. A placebo-controlled comparative trial. Arch Dermatol 1987 : 123 (7 885 889.
22. Foged E, Holm P, Larsen PO. A randomized trial of etretinate (Tigason) in palmoplantar pustulosis. Dermatologica 1983 : 166 (4 220 223.
23. White SI, Marks JM, Shuster S. Etretinate in pustular psoriasis of palms and soles. Br J Dermatol 1985 : 113 (5 581 585.
24. White SI, Puttick L, Marks JM. Low-dose etretinate in the maintenance of remission of palmoplantar pustular psoriasis. Br J Dermatol 1986 : 115 (5 577 582.
25. Marsland AM, Chalmers RJ, Hollis S, Leonardi-Bee J, Griffiths CE. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev 2006 : CD001433.
26. Uehara M, Ofuji S. The morphogenesis of pustulosis palmaris et plantaris. Arch Dermatol 1974 : 109 (4 518 520.